MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patientsCAPPUZZO, F; JÄNNE, P. A; DESTRO, A et al.Annals of oncology. 2009, Vol 20, Num 2, pp 298-304, issn 0923-7534, 7 p.Article

LE GANGLION SENTINELLE DANS LES CANCERS COLIQUES STADES I ET II : Valeur sur le statut lymphatique régional -Étude prédictiveBIANCHI, P. P; ROTTOLI, M; BARTOLUCCI, C et al.Le Journal de coelio-chirurgie (Valence). 2007, Num 64, pp 55-60, issn 1167-8224, 6 p.Article

Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancerSANTORO, A; CAVINA, R; ALLOISIO, M et al.Annals of oncology. 2004, Vol 15, Num 1, pp 33-37, issn 0923-7534, 5 p.Article

A morphometric study of liver cell dysplasiaRONCALLI, M; BORZIO, M; TOMBESI, M. V et al.Human pathology. 1988, Vol 19, Num 4, pp 471-474, issn 0046-8177Article

Reproducibility of the WHO classification of thymomas: Practical implicationsZUCALI, P. A; DI TOMMASO, L; RONCALLI, M et al.Lung cancer. 2013, Vol 79, Num 3, pp 236-241, issn 0169-5002, 6 p.Article

Fractional allelic loss in non-end-stage cirrhosis : Correlations with hepatocellular carcinoma development during follow-upRONCALLI, M; BIANCHI, P; GRIMALDI, G. C et al.Hepatology (Baltimore, Md.). 2000, Vol 31, Num 4, pp 846-850, issn 0270-9139Article

The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver : Implications for diagnosis and classificationRONCALLI, M; ROZ, E; COGGI, G et al.Hepatology (Baltimore, Md.). 1999, Vol 30, Num 5, pp 1174-1178, issn 0270-9139Article

Patterns of integrin common chain β1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and sizePATRIARCA, C; RONCALLI, M; GAMBACORTA, M et al.Journal of pathology. 1993, Vol 171, Num 1, pp 5-11, issn 0022-3417Article

Early changes in the calcitonin gene-related peptide (CGRP) content of pulmonary endocrine cells concomitant with vascular remodeling in the hypoxic ratRONCALLI, M; SPRINGALL, D. R; MAGGIONI, M et al.American journal of respiratory cell and molecular biology. 1993, Vol 9, Num 5, pp 467-474, issn 1044-1549Article

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesisCELESTI, G; CARO, G. D; RONCALLI, M et al.British journal of cancer. 2013, Vol 109, Num 9, pp 2424-2433, issn 0007-0920, 10 p.Article

Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosisBORZIO, M; TRERE, D; BORZIO, F et al.MP. Molecular pathology. 1998, Vol 51, Num 2, pp 96-101, issn 1366-8714Article

Prognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinomaVIALE, G; RONCALLI, M; GRIMELIUS, L et al.Human pathology. 1995, Vol 26, Num 9, pp 945-950, issn 0046-8177Article

C-myc and tumour suppressor gene product expression in developing and term human trophoblastRONCALLI, M; BULFAMANTE, G; VIALE, G et al.Placenta (Eastbourne). 1994, Vol 15, Num 4, pp 399-409, issn 0143-4004Article

Immunophenotypic analysis of the transformation zone of human cervixRONCALLI, M; SIDERI, M; GIE, P et al.Laboratory investigation. 1988, Vol 58, Num 2, pp 141-149, issn 0023-6837Article

Cytology of yolk-sac tumor of the ovary in ascitic fluid (report of a case)RONCALLI, M; GRIBAUDI, G; SIMONCELLI, D et al.Acta cytologica. 1988, Vol 32, Num 1, pp 113-116, issn 0001-5547Article

Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatinGIOVANNETTI, E; ZUCALI, P. A; RONCALLI, M et al.British journal of cancer. 2011, Vol 105, Num 10, pp 1542-1553, issn 0007-0920, 12 p.Article

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitorsZUCALI, P. A; RUIZ, M. G; RONCALLI, M et al.Annals of oncology. 2008, Vol 19, Num 9, pp 1605-1612, issn 0923-7534, 8 p.Article

EGFR overexpression in malignant pleural mesothelioma an immunohistochemical and molecular study with clinico-pathological correlationsDESTRO, A; CERESOLI, G. L; RIZZI, A et al.Lung cancer. 2006, Vol 51, Num 2, pp 207-215, issn 0169-5002, 9 p.Article

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZDI839) in non-small-cell lung cancerPARRA, H. S; CAVINA, R; LATTERI, F et al.British journal of cancer. 2004, Vol 91, Num 2, pp 208-212, issn 0007-0920, 5 p.Article

Clinical histopathology and ultrastructural analysis of myocardium following microwave energy ablationMANASSE, E; COLOMBO, P. G; BARBONE, A et al.European journal of cardio-thoracic surgery. 2003, Vol 23, Num 4, pp 573-577, issn 1010-7940, 5 p.Article

Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patientsLAGHI, L; BIANCHI, P; ORBETEGLI, O et al.British journal of cancer. 2001, Vol 84, Num 2, pp 196-198, issn 0007-0920Article

Cell cycle-related gene abnormalities and product expression in esophageal carcinomaRONCALLI, M; BOSARI, S; MARCHETTI, A et al.Laboratory investigation. 1998, Vol 78, Num 9, pp 1049-1057, issn 0023-6837Article

Ultrasonography-detected macroregenerative nodules in cirrhosis : A prospective studyBORZIO, M; BORZIO, F; CROCE, A et al.Gastroenterology (New York, NY. 1943). 1997, Vol 112, Num 5, pp 1617-1623, issn 0016-5085Article

Liver-cell dysplasia and hepatocellular carcinomaPODDA, M; RONCALLI, M; BATTEZZATI, P. M et al.The Italian journal of gastroenterology. 1992, Vol 24, Num 1, pp 39-42, issn 0392-0623Article

Page / 2